Article
A peptide derived from hepatitis C virus (HCV) core protein inducing cellular responses in patients with HCV with various HLA class IA alleles.
Journal of medical virology - 1 Jul 2009
Niu Yamei, Komatsu Nobukazu, Komohara Yoshihiro, Matsueda Satoko, Yutani Shigeru, Ishihara Yuki, Itou Minoru, Yamada Akira, Itoh Kyogo, Shichijo Shigeki
Abstract excerpt
C35-44 peptide is a well known HLA-A2-restricted CTL epitope originating from hepatitis C virus (HCV) core protein. It was reported that the majority of HCV positive patients had significant levels of serum IgG specific to this peptide. This study addressed whether C35-44 peptide could induce CTL activity restricted to various HLA class IA alleles or could not. This peptide demonstrated binding activity to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
